For: | Choi GH, Jang ES, Kim JW, Jeong SH. Prognostic role of plasma level of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factor in hepatocellular carcinoma. World J Gastroenterol 2021; 27(27): 4453-4467 [PMID: 34366616 DOI: 10.3748/wjg.v27.i27.4453] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i27/4453.htm |
Number | Citing Articles |
1 |
Jia-Yi Du, Chu-Ting Zhang, Ting Li, Ya-Ping Li. Targeting hypoxia and angiogenesis in hepatocellular carcinoma: New insights and therapeutic strategies. World Journal of Hepatology 2024; 16(12): 1371-1376 doi: 10.4254/wjh.v16.i12.1371
|
2 |
Rina Masadah, Andriany Qanitha, Rif'at Hanifah, Muhammad Azka Al Atsari, Andi Nurdahlia, Faturrahman Muiz, Rezky Aulia Yusuf. The potential role of Vascular Endothelial Growth Factor for hepatocellular carcinoma screening: a systematic review. F1000Research 2024; 13: 749 doi: 10.12688/f1000research.145606.1
|
3 |
Takahiro Shimazaki, Nobuhiro Noro, Kazuhiro Hagikura, Taro Matsumoto, Chikako Yoshida-Noro. Quantitative Analysis of Factors Regulating Angiogenesis for Stem Cell Therapy. Biology 2021; 10(11): 1212 doi: 10.3390/biology10111212
|
4 |
Yung-Fang Hsiao, Shao-Bin Cheng, Chia-Yu Lai, Hsiao-Tien Liu, Hui-Chen Lin, Yi-Chia Huang. Vascular endothelial growth factor is associated with hepatocellular carcinoma recurrence, independent of folate and glutathione-related antioxidant enzymes: A follow-up study. Nutrition Research 2024; 128: 70 doi: 10.1016/j.nutres.2024.06.010
|
5 |
Lucia Cerrito, Maria Elena Ainora, Carolina Mosoni, Raffaele Borriello, Antonio Gasbarrini, Maria Assunta Zocco. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy. Cancers 2022; 14(19): 4647 doi: 10.3390/cancers14194647
|
6 |
Xiaojiao Sun, Zhuo Zhang, Zhiqi Wang, Ran Xie, Chuxiao Yi, Huiyu Liu, Xiaowei Chi, Tiancheng Li, Haitao Liu, Yi Han, Xiaocong Pang, Yimin Cui, Zhenming Liu. The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1033967
|
7 |
Yan-Dong Miao, Xiao-Long Tang, Jiang-Tao Wang, Deng-Hai Mi. Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis. World Journal of Gastroenterology 2022; 28(30): 4221-4226 doi: 10.3748/wjg.v28.i30.4221
|
8 |
Wang Li, Ruichao Wu, Shengning Zhang, Yingpeng Zhao, Laibang Li, Zongqiang Hu, Qiuming Su, Yuanyi Mang, Xibing Zhang, Yun Dong, Kepu Zheng, Jianghua Ran, Li Li. Analysis of angiogenesis-related subtypes of hepatocellular carcinoma and tumor microenvironment infiltration feature in hepatocellular carcinoma. Clinical and Translational Oncology 2023; 25(7): 2099 doi: 10.1007/s12094-023-03084-x
|
9 |
Lavinia Patricia Mocan, Cristiana Grapa, Rareș Crăciun, Ioana Ecaterina Pralea, Alina Uifălean, Andreea Maria Soporan, Ximena Maria Mureșan, Maria Iacobescu, Nadim Al Hajjar, Carmen Mihaela Mihu, Zeno Spârchez, Tudor Mocan, Cristina Adela Iuga. Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1440985
|
10 |
Ying-Hsien Huang, Wei-Shiung Lian, Feng-Sheng Wang, Pei-Wen Wang, Hung-Yu Lin, Ming-Chao Tsai, Ya-Ling Yang. MiR-29a Curbs Hepatocellular Carcinoma Incidence via Targeting of HIF-1α and ANGPT2. International Journal of Molecular Sciences 2022; 23(3): 1636 doi: 10.3390/ijms23031636
|
11 |
Jing Zheng, Pei-Zhuo Du, Cui Yang, Yun-Yun Tao, Li Li, Zu-Mao Li, Lin Yang. DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma. Abdominal Radiology 2023; 48(11): 3343 doi: 10.1007/s00261-023-04007-8
|